<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article article-type="abstract" dtd-version="1.0" xml:lang="en" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">CC</journal-id>
<journal-id journal-id-type="nlm-ta">Cardiol Croat</journal-id>
<journal-title-group>
<journal-title>Cardiologia Croatica</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Cardiol. Croat.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">1848-543X</issn>
<issn pub-type="epub">1848-5448</issn>
<publisher><publisher-name>Croatian Cardiac Society</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">CC_13(5-6)_186</article-id>
<article-id pub-id-type="doi">10.15836/ccar2018.186</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Extended Abstract</subject></subj-group>
</article-categories>
<title-group>
<article-title>Atrial fibrillation in patients with mitral regurgitation</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8664-3338</contrib-id><name><surname>Planini&#x0107;</surname><given-names>Zrinka</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7904-8899</contrib-id><name><surname>Per&#x010D;i&#x0107;</surname><given-names>Marko</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5989-6495</contrib-id><name><surname>Pa&#x0161;ali&#x0107;</surname><given-names>Ante</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3189-8661</contrib-id><name><surname>Fri&#x0161;&#x010D;i&#x0107;</surname><given-names>Tea</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8502-7816</contrib-id><name><surname>Gulin</surname><given-names>Dario</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0555-6863</contrib-id><name><surname>Adrovi&#x0107;</surname><given-names>Leon</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9701-0253</contrib-id><name><surname>Be&#x0161;i&#x0107;</surname><given-names>Dijana</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4488-0559</contrib-id><name><surname>&#x0160;iki&#x0107;</surname><given-names>Jozica</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<aff id="aff1"><label>1</label><institution>University Hospital &#x201C;Sveti Duh&#x201D;</institution>, <addr-line>Zagreb</addr-line>, <country>Croatia</country></aff>
<aff id="aff2"><label>2</label><institution>University of Zagreb School of Medicine</institution>, <addr-line>Zagreb</addr-line>, <country>Croatia</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>*</label>ADDRESS FOR CORRESPONDENCE: Zrinka Planini&#x0107;, Klini&#x010D;ka bolnica &#x201E;Sveti Duh&#x201C;, Sv. Duh 64, HR-10000 Zagreb, Croatia. / Phone: +385-91-3714-308 / E-mail: <email xlink:href="zrinkaplaninic@gmail.com">zrinkaplaninic@gmail.com</email></corresp></author-notes>
<pub-date pub-type="epub-ppub"><month>06</month><year>2018</year></pub-date>
<volume>13</volume>
<issue>5-6</issue>
<fpage>186</fpage>
<lpage>186</lpage>
<history>
<date date-type="received"><day>30</day><month>04</month><year>2018</year></date><date date-type="accepted"><day>10</day><month>05</month><year>2018</year></date>
</history>
<permissions>
<copyright-year>2018</copyright-year>
<copyright-holder>Croatian Cardiac Society</copyright-holder>
</permissions>
<kwd-group kwd-group-type="author"><title>Keywords: </title><kwd>atrial fibrillation</kwd><kwd>mitral regurgitation</kwd><kwd>coronary artery disease</kwd></kwd-group>
</article-meta>
</front>
<body>
<p><bold>Background</bold>: Mitral regurgitation (MR) is often complicated with atrial fibrillation (AF), with estimated rate of 5% per year. Patients with both MR and AF have higher risk of cardiac events (<xref ref-type="bibr" rid="r1"><italic>1</italic></xref>). The aim of our study was to investigate how many of patients with MR have AF, and is there any correlation with the severity of MR and AF occurrence.</p>
<p><bold>Patients and Methods:</bold> Retrospective study was conducted to investigate frequency of AF in patients with MR. A total number of 686 patients were included, 45% were female. The prevalence of arterial hypertension, diabetes mellitus, hyperlipidemia were similar between men and women. When compared to women, men smoke more frequently. On the other hand, women had higher serum uric acid levels.</p>
<p><bold>Results</bold>: Atrial fibrillation was found in 44% of patients with MR. Almost half of women (49.5%) and 39.5% of men with MR had AF. Paroxysmal AF was present in 38.7%, and permanent in 27.4% of patients with MR. 45% of patients had mild, 36.4% had moderate, and 18.6% had severe MR. 25.5% of men and 18.3% of women had concomitant AF and severe MR. Mitral regurgitation was associated with AF and coronary artery disease in 16.2% of cases, with 53% having mild MR.</p>
<p><bold>Conclusion</bold>: Atrial fibrillation can often be found in patients with mitral regurgitation. Mild MR was more often associated with AF occurrence, as well as in patients with both AF and CAD.</p>
</body>
<back>
<ref-list>
<title>LITERATURE</title>
<ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herrmann</surname><given-names>HC</given-names></name><name><surname>Gertz</surname><given-names>ZM</given-names></name><name><surname>Silvestry</surname><given-names>FE</given-names></name><name><surname>Wiegers</surname><given-names>SE</given-names></name><name><surname>Woo</surname><given-names>YJ</given-names></name><name><surname>Hermiller</surname><given-names>J</given-names></name><etal/></person-group> <article-title>Effects of atrial fibrillation on treatment of mitral regurgitation in the EVEREST II (Endovascular Valve Edge-to-Edge Repair Study) randomized trial.</article-title> <source>J Am Coll Cardiol</source>. <year>2012</year> Apr 3;<volume>59</volume>(<issue>14</issue>):<fpage>1312</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2011.12.023</pub-id><pub-id pub-id-type="pmid">22464260</pub-id></mixed-citation></ref>
</ref-list>
</back>
</article>
